Hansoh Pharmaceutical Group Company Limited Stock OTC Markets
Equities
HNSPF
KYG549581067
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | +19.75% | -.--% | +2.73% |
04-30 | Hansoh Pharmaceutical’s 2023 Profit Up 27% | MT |
04-29 | Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024 | CI |
Sales 2024 * | 11.83B 1.63B 2.25B | Sales 2025 * | 12.48B 1.72B 2.37B | Capitalization | 97.91B 13.51B 18.59B |
---|---|---|---|---|---|
Net income 2024 * | 3.77B 521M 716M | Net income 2025 * | 3.79B 523M 720M | EV / Sales 2024 * | 6.48 x |
Net cash position 2024 * | 21.23B 2.93B 4.03B | Net cash position 2025 * | 23.86B 3.29B 4.53B | EV / Sales 2025 * | 5.93 x |
P/E ratio 2024 * |
25.5
x | P/E ratio 2025 * |
25.7
x | Employees | 9,123 |
Yield 2024 * |
0.93% | Yield 2025 * |
0.96% | Free-Float | 18.22% |
1 day | +19.75% | ||
3 months | +19.75% | ||
6 months | +2.73% | ||
Current year | +2.73% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Juan Zhong
CEO | Chief Executive Officer | 63 | 15-12-01 |
Sheng Li Zhong
SEC | Corporate Secretary | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Qiang Lin
BRD | Director/Board Member | 81 | 19-05-30 |
Sheung Wai Chan
BRD | Director/Board Member | 70 | 19-06-13 |
Dong Tao Yang
BRD | Director/Board Member | 67 | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- 3692 Stock
- HNSPF Stock